Pulmonary Artery Catheter Market Report 2025

This pulmonary artery catheter market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The pulmonary artery catheter market size has grown steadily in recent years. It will grow from $1.2 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the rise in the aging population, rising demand for minimally invasive surgeries, high prevalence of diabetes and hypertension, increasing prevalence of cardiovascular and pulmonary diseases, and rising demand for advanced hemodynamic monitoring systems.

The pulmonary artery catheter market size is expected to see steady growth in the next few years. It will grow to $1.51 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing health problems due to sedentary lifestyles and unhealthy dietary habits, increased prevalence of smoking and alcohol consumption, increasing investments in the healthcare sector, increasing incidence of heart and lung diseases, and rising healthcare expenditure. Major trends in the forecast period include non-invasive or minimally invasive techniques such as echocardiography and less invasive hemodynamic monitoring devices, sterile techniques, proper catheter placement verification, continuous monitoring of complications, integration with advanced monitoring systems, and customization and personalization of hemodynamic monitoring.

The anticipated growth of the pulmonary artery catheter market is expected to be driven by the rising incidence of heart and lung diseases. This increase in prevalence can be attributed to various factors, including unhealthy diets, sedentary lifestyles, environmental and social influences, and gaps in diagnosis and treatment. Pulmonary artery catheters play a crucial role in monitoring heart and lung function by measuring pressures within the pulmonary artery, aiding in the diagnosis and management of these conditions. For example, in June 2024, the Australian Institute of Health and Welfare reported that approximately 638,000 Australians, or 2.5% of the population, were living with chronic obstructive pulmonary disease in 2022. Additionally, the Centers for Disease Control and Prevention noted in May 2024 that heart disease was responsible for 702,880 deaths in 2022 in the U.S., representing 1 in every 5 deaths. Consequently, the increasing incidence of heart and lung diseases is fueling the growth of the pulmonary artery catheter market.

Leading companies in the pulmonary artery catheter market are focusing on developing advanced endovascular catheters to improve the accuracy of hemodynamic monitoring, enhance patient safety, and support minimally invasive procedures for evaluating cardiac function and pulmonary pressures. Endovascular catheters are specialized devices designed for precise catheterization and monitoring of the pulmonary artery. For instance, in January 2024, Thrombolex, Inc., a U.S.-based medical device company, introduced the BASHIR.035 and BASHIR S-B endovascular catheters for treating acute pulmonary embolism (PE). These catheters, designed to work with a 0.035 guidewire, feature an expandable infusion basket that allows for targeted thrombolysis by delivering thrombolytics directly into the clot. This method aims to quickly restore blood flow, enhancing patient safety and reducing procedure duration.

In September 2024, Becton, Dickinson and Company (BD), a US-based medical device company, acquired Edwards Lifesciences for an undisclosed sum. The acquisition is designed to strengthen BD's portfolio of critical care products and bolster its market position in advanced patient monitoring solutions. Edwards Lifesciences, also a US-based medical device company, specializes in innovative heart valve solutions, hemodynamic monitoring, and critical care technologies.

Major companies operating in the pulmonary artery catheter market are Cardinal Health Corp, Medtronic Inc., Becton Dickinson And Company, Philips Healthcare Corp, Stryker Corporation, Boston Scientific Corporation, Medline Industries Inc., B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Zoll Medical Corporation, Nipro Corporation, Smiths Medical Group, Teleflex Incorporated, Merit Medical Systems Inc., DeRoyal Industries Inc., Vygon SA, AngioDynamics Inc., Relisys Medical Devices Limited, QXMédical LLC.

North America was the largest region in the pulmonary artery catheter market in 2024. The regions covered in the pulmonary artery catheter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonary artery catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A pulmonary artery catheter (PAC) is a specialized medical device designed to measure pressures within the heart and pulmonary artery. It provides essential information about cardiovascular function, especially for patients with severe heart or lung conditions. PACs are frequently used in intensive care settings to monitor cardiac output, pulmonary artery pressure, and other hemodynamic parameters.

The main types of pulmonary artery catheters include four-lumen, five-lumen, six-lumen, and other variations. A four-lumen catheter is a device with four distinct channels that serve various functions such as monitoring, medication delivery, and blood sampling through arterial access. These catheters are used in intensive care units (ICUs), non-intensive care units, hospitals, long-term care facilities, and other healthcare settings.

The pulmonary artery catheter market research report is one of a series of new reports that provides pulmonary artery catheter market statistics, including the pulmonary artery catheter industry's global market size, regional shares, competitors with a pulmonary artery catheter market share, detailed pulmonary artery catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary artery catheter industry. This pulmonary artery catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary artery catheter market consists of sales of swan-ganz catheters, heparin-bonded catheters, multi-lumen catheters, temperature-sensing catheters, and pressure monitoring catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.